Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event

Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model

Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans